Timothy Hamill, MD

Director of UCSF Clinical Laboratories

Dr. Timothy Hamill is the director of Clinical Laboratories at UCSF Medical Center's China Basin and Parnassus campuses. In addition, he is the vice chair of the UCSF Department of Laboratory Medicine. Hamill also is a director of the inpatient and outpatient laboratories as well as Point of Care Testing laboratories at Parnassus. As director of the various clinical laboratories, Hamill is responsible for the overall administration and planning of laboratory operations and clinical consultations for testing at the different UCSF Medical Center sites.

Hamill is a member of numerous UCSF Medical Center committees and professional societies. Currently, he holds the position of chair of the UCSF Medical Center Point of Care Testing Committee. He is also a member of the California Department of Health Services Clinical Laboratory Technology Advisory Committee (CLTAC), American Society of Hematology, Academy of Clinical Laboratory Physicians and Scientists, and California Society of Pathologists. In addition, Hamill is a fellow of the American Society of Clinical Pathologists and College of American Pathologists.

Hamill completed his medical degree from UC Davis' School of Medicine. He was the chief resident in the departments of Laboratory Medicine at UCSF and San Francisco General Hospital. In addition, he completed a fellowship in hematopathology at the Veterans Administration Medical Center in Martinez, Calif.

More about Timothy Hamill


UC Davis School of Medicine 1983


UCSF Medical Center, Laboratory Medicine 1988


Veterans Affairs Medical Center, Martinez, Calif., Hematopathology 1990

Selected Research and Publications

  1. Bowman C, Hamill T. Assuring quality in point-of-care testing. Arch Pathol Lab Med. 2012 May; 136(5):472-3.
  2. Terrazas E, Hamill TR, Wang Y, Channing Rodgers RP. Creating a clinical video-conferencing facility in a security-constrained environment using open-source AccessGrid software and consumer hardware. AMIA Annu Symp Proc. 2007 Oct 11; 716-20.
  3. Astion ML, Shojania KG, Hamill TR, Kim S, Ng VL. Classifying laboratory incident reports to identify problems that jeopardize patient safety. Am J Clin Pathol. 2003 Jul; 120(1):18-26.
  4. Perrier ND, Ituarte PH, Morita E, Hamill T, Gielow R, Duh QY, Clark OH. Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab. 2002 Mar; 87(3):1024-9.
  5. Perrier ND, Ituarte P, Kikuchi S, Siperstein AE, Duh QY, Clark OH, Gielow R, Hamill T. Intraoperative parathyroid aspiration and parathyroid hormone assay as an alternative to frozen section for tissue identification. World J Surg. 2000 Nov; 24(11):1319-22.
  6. Cha I, Herndier BG, Glassberg AB, Hamill TR. A case of composite Hodgkin's disease and chronic lymphocytic leukemia in bone marrow. Lack of Epstein-Barr virus. Arch Pathol Lab Med. 1996 Apr; 120(4):386-9.
  7. Hamill TR, Hamill SG, Busch MP. Effects of room-temperature exposure on bacterial growth in stored red cells. Transfusion. 1990 May; 30(4):302-6.
  8. Hamill TR. The 30-minute rule for reissuing blood: are we needlessly discarding units? Transfusion. 1990 Jan; 30(1):58-62.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.